Applied Biomimetic Highlights DairySep™ Product at Membrane Technology Forum

11 June, 2019
For Public Release

Gaithersburg, MD ‐‐ Applied Biomimetic, a leader in the convergence of polymer and protein membrane technologies, is showcasing its DairySep™ high performance ultrafiltration at the Membrane Technology Forum in Minneapolis this week.

William Harvey, Applied Biomimetic Vice President, commented “We have participated in this conference ever since we launched our DairySep™ ultrafiltration elements three years ago. The engagement level with our customers in the dairy and enzyme industry is very high at this conference, and there is real interest experiencing the highest productivity ultrafiltration elements available in the industry.”

Commenting further: “Our products are in eight live production environments at some of the largest dairy facilities in Europe and North America, and this conference is a unique venue to convey our DairySep™ product value proposition and accelerating customer adoption.”

More information on the conference can be found at

About Applied Biomimetic A/S:

Applied Biomimetic is a leader in the convergence of polymer and protein membrane technology. We have developed a high‐performance membrane platform for water, life science, enzyme, food, and dairy separation applications.

Our core technology is based on new chemistry and manufacturing methods to achieve highly permeable membrane material with narrow molecular size exclusion cut‐off. By adding an active protein layer, the membranes will separate constituents at the ion level. We specialize in block copolymer synthesis and lamellar phases self‐assembly. Applied Biomimetic holds global patents for the concept of embedding proteins in a proprietary polymeric membrane structure. We are also recognized as a leader in the expression, purification, and production scale‐up of porins from biological sources as well as synthesis of various types of polymeric amphiphiles.

We foresee a number of new innovative applications for our technology platform that may be established at a later stage, e.g. new delivery mechanisms for pharmaceuticals, new coatings for contact lenses, and more effective products for the cosmetics industry.